show episodes
 
Podcast of The Journal of Nuclear Medicine (JNM)—a leading medical imaging journal self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). In JNM Podcast, our esteemed editors speak with experts in the field to discuss emerging technologies and rapidly changing issues in practice and research. JNM: https://jnm.snmjournals.org SNMMI: http://www.snmmi.org
  continue reading
 
Artwork

1
Radiology Podcasts | RSNA

The Radiological Society of North America

Unsubscribe
Unsubscribe
Ogni settimana
 
Radiology Podcast Editor Linda Chu, MD and guests discuss recently published research in the January 2021 Issue of Radiology. Subscribe today on Apple Podcasts, Google Play, Spotify, or ask Alexa to "play Radiology podcasts on TuneIn".
  continue reading
 
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
  continue reading
 
Welcome to the "Nuclear Lounge” podcast, a podcast dedicated to students and the Nuclear Medicine community. I am your host, Fernando Anleu. I am a Nuclear Medicine Technologist, and it is my honor to guide you through this captivating journey into the world of nuclear medicine.
  continue reading
 
Loading …
show series
 
Dr. Linda Chu speaks with Dr. Giuseppe Esposito, Dr. Yasar Torres-Yaghi, and Dr. Lydia Wood to explore how the availability of amyloid PET imaging and other advanced neuroimaging techniques is transforming the diagnostic and treatment landscape for neurodegenerative disorders. Sponsored by GE HealthCare.…
  continue reading
 
Dr. Linda Chu discusses the partnership among GE HealthCare, RSNA, and Muhimbili National Hospital with Dr. Toma Omofoye, Dr. Priyanka Jha, Dr. Lulu Fundikira, Dr. Fred Lyimo, and Maria Smith. This episode is sponsored by GE HealthCare.
  continue reading
 
Radioligand therapy (RLT) targets cancer cells with radiation while minimizing impact on surrounding healthy tissue. In this episode of JNM Podcast, our panelists discuss training, access, production capacity, and everything else that is necessary to make RLT more widely available to the patients who need it. Moderator: Ken Herrmann, MD (Universitä…
  continue reading
 
Dr. Reni Butler discusses the impact of patient characteristics on AI performance on negative screen digital breast tomosynthesis with Dr. Derek Nguyen, Dr. Yinhao Ren, and Dr. Lars Grimm. Patient Characteristics Impact Performance of AI Algorithm in Interpreting Negative Screening Digital Breast Tomosynthesis Studies. Nguyen and Ren et al. Radiolo…
  continue reading
 
Dr. Linda Chu summarizes recent review articles on NASH, liver MR elastography, and LI-RADS contrast enhanced US nonradiation treatment assessment algorithm. Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024. Lyshchik et al. Radiology 2024; 311(2):e232369. Interpretation, Reporting,…
  continue reading
 
Dr. Ashwin Singh Parihar discusses the role of multiparametric MRI and 18F-PSMA-1007 PET/CT for the detection of clinically significant prostate cancer with Dr. Bastiaan Privé. This episode is sponsored by Mayo Clinic. Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer. Privé et al. Radiology 20…
  continue reading
 
Dr. Linda Chu discusses predictors of intestinal resection-free survival in patients with acute arterial mesenteric ischemia with Dr. Lorenzo Garzelli and Dr. Maxime Ronot. Predictors of Survival Without Intestinal Resection after First-Line Endovascular Revascularization in Patients with Acute Arterial Mesenteric Ischemia. Garzelli et al. Radiolog…
  continue reading
 
Join us on this episode as we welcome Cybil Nielsen, a leading figure in the nuclear medicine community. Cybil brings her extensive experience and advocacy efforts to the forefront, discussing her work with legislative initiatives impacting the field. Tune in to hear her insights on the future of nuclear medicine, the critical role of policy change…
  continue reading
 
The VISION Trial is the first-in-its-field study to use radiopharmaceuticals that directly target prostate cancer tumors. Hear from one of the lead researchers on this ground-breaking study as he discusses how the trial has opened up a completely new field of study in prostate cancer research and shaped the future of nuclear medicine therapy in com…
  continue reading
 
Guest: Phillip H. Kuo, MD, PhD One of the major changes that's occurred very recently in the field of neurodegenerative disease and Alzheimer's disease, specifically, are the recently approved antibody therapies that remove amyloid from the brain, which is one of the culprit proteins in Alzheimer's disease. To learn more about this presentation fro…
  continue reading
 
Guest: Geoffrey B. Johnson, M.D., Ph.D. When looking at patients who suffer from prostate cancer who are receiving PSMA therapy, we can see on our images that the medication not only goes to their cancer, but it also goes to some other things in their body, including the salivary glands. To learn more about his recent study on salivary toxicity, jo…
  continue reading
 
Host: Jennifer Caudle, DO Guest: Geoffrey B. Johnson, M.D., Ph.D. Prostate-specific membrane antigen (PSMA) PET scans are a method by which clinicians can see if a patient who is suffering from prostate cancer has tumors that are expressing the PSMA target. In addition to that, the scan allows us to measure how much of the medication we get onto th…
  continue reading
 
Guest: Joyita Dutta The AI landscape is evolving at a rapid pace. However, there is a shortage of large public data sets in nuclear medicine that AI models can be trained on. To learn more about what’s on the AI horizon and the challenges that are associated, join Dr. Joyita Dutta, Associate Professor at the University of Massachusetts, Amherst in …
  continue reading
 
Guest: Geoffrey B. Johnson, M.D., Ph.D. Clinicians are hopeful that theranostics could help treat patients as soon as they go metastatic or even before surgery to try to affect their therapy and possibly get them to avoid having to take toxic or high side effect therapies. To hear more, tune in with Dr. Geoffrey Johnson, Nuclear Medicine Specialist…
  continue reading
 
Guest: Brianna Cagle The Discovery Team at Perspective has developed a compound, called PSV-359, which is a cyclic peptide radiopharmaceutical. It targets a protein, called fibroblast activation protein (FAP), which is a pan-cancer target and is expressed in a wide variety of cancers. To learn more about her presentation from SNMMI 2024, hear from …
  continue reading
 
June is Alzheimer and brain awareness month. This is a re-release to a podcast episode from December 2022 that focuses on this important topic. Dr. Manisha Bahl interviews Dr. Jeffrey Prescott. Diffuse Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort. Prescott et al. Radi…
  continue reading
 
Host: Jody Takemoto, PhD Guest: Bryson Katona, MD, PhD At the 2024 Digestive Disease Week Annual Meeting, Dr. Bryson Katona presented a session, titled “High-Risk Colon Cancer: The ABCs of Genetic Testing.” And now, Dr. Katona is here with Dr. Jody Takemoto to share key insights from his session on genetic testing for patients with high-risk colon …
  continue reading
 
Guest: Lillian Siu, MD, FRCPC With a few studies in the works for cancer vaccines, the future is exciting for what this could mean for oncology patients. Dive in to learn about the various ways to package cancer vaccines so they can be delivered to patients effectively. And to learn more about the limitations, targets, and platforms of cancer vacci…
  continue reading
 
Guest: Lillian Siu, MD, FRCPC Since cancer vaccines have been of interest to oncologists for decades, they’ve been trying to figure out how to prime or stimulate the immune system to attack cancer, and until the last few years, cancer vaccines have been challenging. To learn about this unique area of study, which she also presented at ASCO 2024, jo…
  continue reading
 
Dr. Lauren Kim discusses the role of large language models in simplifying radiology reports with Kanhai Amin and Dr. Howard Forman. Accuracy of ChatGPT, Google Bard, and Microsoft Bingfor Simplifying Radiology Reports. Amin et al. Radiology 2023; 309(2):e232561. Quantitative Evaluation of Large LanguageModels to Streamline Radiology Report Impressi…
  continue reading
 
Guest: Andres J. Yarur, MD Obesity has recently surfaced as an important topic in patients with inflammatory bowel diseases, such as Crohn’s and ulcerative colitis, but historically, these patients have been underweight. This led to the phase III pivotal trials for the use of upadacitinib in patients with moderate to severe ulcerative colitis and C…
  continue reading
 
Guest: Tyler J Bradshaw, PhD In recent years, doctors have become interested in how large language models and AI technologies could potentially improve radiology overall. Even though these technologies are still in the beginning stages of being used in medicine, eventually doctors hope to show what impact they could have on patients. To learn more …
  continue reading
 
Dr. Linda Chu discusses the Consensus Recommendations on Percutaneous Bone Biopsies for Chronic Nonspinal Osteomyelitis with Dr. Laura Fayad. Chronic Nonspinal Osteomyelitis in Adults: Consensus Recommendations on Percutaneous Bone Biopsies from the Society of Academic Bone Radiologists. Debs et al. Radiology 2024; 311(1):e231348.…
  continue reading
 
Welcome to another episode of the Nuclear Lounge Podcast! Today, we have a very special guest with us, someone whose contributions to the field of nuclear medicine are truly remarkable. Tina Brennan is a seasoned professional with over 22 years of experience in nuclear medicine. Her extensive career has seen her evolve from a passionate beginner to…
  continue reading
 
The Journal of Nuclear Medicine presents a new podcast on advances in dementia imaging. Panelists discuss the importance of amyloid and tau PET imaging in dementia diagnosis and treatment, highlighting their roles in clinical trials and future therapies. They emphasize the significance of early detection and the potential for personalized medicine …
  continue reading
 
This month's episode of the JNM Podcast takes the discussion of Pb-212 worldwide! Researchers from the UK, Australia, and North America discuss the logistics of using lead-212 as a radionuclide imaging agent. From availability to production to transportation, Pb-212 presents both great opportunities and great challenges. Moderator Ken Herrmann, MD,…
  continue reading
 
The Journal of Nuclear Medicine presents a new podcast on FAPI-directed theranostics for cancer diagnosis and treatment. Join moderator Ken Herrmann (Universitätsmedizin) and panelists Andrew Scott (Austin Health), Katharina Lückerath (Universitätsmedizin) and Shadi Esfahadi (Mass General Hospital) as they delve into the history of FAP, discuss cha…
  continue reading
 
Dr. Reni Butler discusses AsymMirai, interpretable mammography-based deep learning model for breast cancer risk prediction with Jon Donnelly, Luke Moffett, Dr. Schwartz, and Dr. Joseph Lo. AsymMirai: Interpretable Mammography-based Deep Learning Model for 1–5-year Breast Cancer Risk Prediction. Donnelly et al. Radiology 2024; 310(3):e232780.…
  continue reading
 
Loading …

Guida rapida